Deep Track Capital, LP

Investment Portfolio & 13F Holdings Analysis

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
69
Total Value
3088173822
Accession Number
0001856083-25-000002
Form Type
13F-HR
Manager Name
Deep Track Capital, LP
Data Enrichment
93% identified
64 identified5 unidentified

Holdings

69 positions
Manager:
Search and click to pin securities to the top
Page 1 of 4
46116X101
Shares:
2000000(+0.0%)
Value:
$263.8B(+58.0%)
Guardant Health, Inc.
Shares:
5443721(-15.2%)
Value:
$231.9B(+18.2%)
DYNAVAX TECHNOLOGIES CORP
Shares:
17791486(+0.0%)
Value:
$230.8B(+1.6%)
Immunovant, Inc.
Shares:
9500000(+58.3%)
Value:
$162.4B(+9.2%)
Protagonist Therapeutics, Inc
Shares:
3000000(+200.0%)
Value:
$145.1B(+275.9%)
IONIS PHARMACEUTICALS INC
Shares:
4564207(+136.0%)
Value:
$137.7B(+103.7%)
Akero Therapeutics, Inc.
Shares:
3210270(+115.5%)
Value:
$130.0B(+213.5%)
CYTOKINETICS INC
Shares:
3073853(+22.9%)
Value:
$123.5B(+5.0%)
Apellis Pharmaceuticals, Inc.
Shares:
5000000(+17.0%)
Value:
$109.3B(-19.8%)
OCULAR THERAPEUTIX, INC
Shares:
14294420(+11.3%)
Value:
$104.8B(-4.4%)
BridgeBio Pharma, Inc.
Shares:
2800000(+241.8%)
Value:
$96.8B(+330.6%)
Tarsus Pharmaceuticals, Inc.
Shares:
1484266
Value:
$76.2B
Viridian Therapeutics, Inc.\DE
Shares:
5380449(+19.0%)
Value:
$72.5B(-16.3%)
Structure Therapeutics Inc.
Shares:
4100000(+46.4%)
Value:
$71.0B(-6.5%)
89bio, Inc.
Shares:
9316333(+43.8%)
Value:
$67.7B(+33.7%)
Nurix Therapeutics, Inc.
Shares:
5500000(+83.3%)
Value:
$65.3B(+15.6%)
GERON CORP
Shares:
38176251(+851.7%)
Value:
$60.7B(+327.5%)
Sarepta Therapeutics, Inc.
Shares:
899731
Value:
$57.4B
Ultragenyx Pharmaceutical Inc.
Shares:
1350000(+106.6%)
Value:
$48.9B(+77.8%)
ANI PHARMACEUTICALS INC
Shares:
700000(+7.8%)
Value:
$46.9B(+30.6%)